152 related articles for article (PubMed ID: 785839)
21. Serial changes in the coagulation system following clotting factor concentrate infusion.
Preston FE; Winfield DA; Malia RG; Blackburn EK
Thromb Diath Haemorrh; 1975 Nov; 34(2):475-82. PubMed ID: 1198408
[TBL] [Abstract][Full Text] [Related]
22. [Hemostatic changes in the course of different chronic hepatopathies].
Ruggiero G; De Biasi R; Lembo N; Giusti G
Minerva Med; 1975 Feb; 66(13):595-601. PubMed ID: 1113909
[TBL] [Abstract][Full Text] [Related]
23. Plasma fibrin stabilising factor (F.S.F.) activity in normal subjects and patients with chronic liver disease.
Walls WD; Losowsky MS
Thromb Diath Haemorrh; 1969 Feb; 21(1):134-43. PubMed ID: 5773724
[No Abstract] [Full Text] [Related]
24. Study on coagulation profile of patients with cirrhosis of the liver undergoing elective fibreoptic injection sclerotherapy of oesophageal varices.
Bernardi M; Palareti G; Pini P; Caletti GC; Brocchi E; Gasbarrini G
Hepatogastroenterology; 1984 Jun; 31(3):125-8. PubMed ID: 6469201
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of C3 and cholinesterase in various diseases of the liver.
Jorge AD; Sanchez D
Acta Hepatogastroenterol (Stuttg); 1976 Feb; 23(1):19-25. PubMed ID: 1258598
[TBL] [Abstract][Full Text] [Related]
26. Coagulation factor concentrate in the treatment of the haemorrhagic diathesis of fulminant hepatic failure.
Gazzard BG; Lewis ML; Ash G; Rizza CR; Bidwell E; Williams R
Gut; 1974 Dec; 15(12):993-8. PubMed ID: 4448416
[TBL] [Abstract][Full Text] [Related]
27. Plasma antithrombin III, alpha 2-plasmin inhibitor and plasminogen activities in cases of various liver diseases.
Ito K; Niwa M; Kawada T; Tanaka Y
Tokai J Exp Clin Med; 1986 Nov; 11(5):345-52. PubMed ID: 3672563
[TBL] [Abstract][Full Text] [Related]
28. The proteinase inhibitor complexes (antithrombin III-thrombin, alpha 2antiplasmin-plasmin and alpha 1antitrypsin-elastase) in septicemia, fulminant hepatic failure and cardiac shock: value for diagnosis and therapy control in DIC/F syndrome.
Egbring R; Seitz R; Blanke H; Leititis J; Kesper HJ; Burghard R; Fuchs G; Lerch L
Behring Inst Mitt; 1986 Feb; (79):87-103. PubMed ID: 2424425
[TBL] [Abstract][Full Text] [Related]
29. Heparin therapy in the case of acute liver cirrhosis.
Fischer M; Gauss P; Korp W; Nobis H; Schnack B; Weissmann A
Scand J Gastroenterol Suppl; 1973; 19():135-8. PubMed ID: 4515636
[No Abstract] [Full Text] [Related]
30. [Substitution therapy with prothrombin complex concentrates in acquired coagulation disorders].
Fischer M
Wien Klin Wochenschr; 1983 Feb; 95(3):82-5. PubMed ID: 6858171
[TBL] [Abstract][Full Text] [Related]
31. [The relationship between hemostatic changes in liver cirrhosis patients with different degrees of liver lesions in reference to Child-Pugh scores].
Cong YL; Wei YX; Zhang LW; Yin ZJ; Bai J
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):31-4. PubMed ID: 15670488
[TBL] [Abstract][Full Text] [Related]
32. [Prothrombin (factor II) in hepatic diseases].
Mannucci PM; Lobina GF; Craveri A; Bragotti R; Cerrini R
G Clin Med; 1968 Dec; 49(12):1311-25. PubMed ID: 5737500
[No Abstract] [Full Text] [Related]
33. [Monitoring blood coagulation in larger liver operations].
Groh J; Welte M; Azad SC; Kratzer MA
Infusionsther Transfusionsmed; 1993 Aug; 20(4):173-9. PubMed ID: 8400798
[TBL] [Abstract][Full Text] [Related]
34. Laboratory assessment of coagulation disorders in liver disease.
Rock WA
Clin Lab Med; 1984 Jun; 4(2):419-42. PubMed ID: 6388986
[TBL] [Abstract][Full Text] [Related]
35. [The liver and plasma coagulation factors. Pathophysiology].
Lasch HG
Thromb Diath Haemorrh Suppl; 1973; 55():37-75. PubMed ID: 4612866
[No Abstract] [Full Text] [Related]
36. [Comparative study of hemostatic changes in acute viral hepatitis and terminal cirrhosis].
Lemberg A; Bengochea L; Pierangeli N
Acta Gastroenterol Latinoam; 1982; 12(4):371-5. PubMed ID: 7185233
[TBL] [Abstract][Full Text] [Related]
37. Factor II related antigen and antithrombin III levels as indicators of liver failure in consumption coagulopathy.
Sié P; Letrenne E; Caranobe C; Genestal M; Cathala B; Boneu B
Thromb Haemost; 1982 Jun; 47(3):218-20. PubMed ID: 6810490
[TBL] [Abstract][Full Text] [Related]
38. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
[TBL] [Abstract][Full Text] [Related]
39. Abnormal bleeding during surgery.
Gans H
Arch Chir Neerl; 1971; 23(1):75-82. PubMed ID: 5579926
[No Abstract] [Full Text] [Related]
40. Relevance of clotting tests in liver disease.
Thachil J
Postgrad Med J; 2008 Apr; 84(990):177-81. PubMed ID: 18424573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
